;The Clinical Assessment Core will provide a range of services to Center investigators to assist in recruitment and the conduct of clinical assessments. Specifically, the Clinical Assessment Core will: (1) Assist in recruitment to Center studies;(2) Assist in assessments in studies by providing clinical and self-report behavioral assessments;(3) Coordinate baseline medical screenings (conducted at the CTSA), (4) Provide diagnostician recruitment, training, and ongoing calibration;(5) Administer a core battery in all Center pilot treatment studies and (where possible) ROIs that includes the Risk Assessment Battery, Beck Depression Inventory, and SF-12. Potential users of the Core will be alerted of the resource availability of the Penn CFAR Clinical Core (co-director: Gross) through a wide variety of mechanisms and by highlighting its services as part of Center wide dissemination efforts. The Clinical Assessment Core will continuously monitor and regularly evaluate each of the services that it will provide. In addition, the functioning of the Clinical Assessment Core as a whole will be evaluated through the use of a standard evaluation form, asking about strengths and weaknesses of the Core, completed by all Center investigators who have had contact with the Core over the previous year. Summary of the feedback from investigators will be given to the Center Executive Committee, Internal Advisory Board, and External Advisory Committee for comments and suggestions. The Clinical Assessment Core will be directed by Paul Crits-Christoph, who has extensive experience as an NIH Center Director and in the assessment of patients for psychiatric studies, and co directed by Pablo Tebas and Robert Gross, who have extensive experience in the treatment of patients with HIV/AIDS and in recruiting such patients for clinical research studies.
The overall aim of the Clinical Assessment Core is to assist investigators in meeting the requirements of clinical psychiatric research for reliable and valid identification and description of patient samples, reliable administration of standard clinical interviews, and collection of self-report measures using procedures that will maximize the reliability and validity ofthe data.
|Dowshen, Nadia; Matone, Meredith; Luan, Xianqun et al. (2016) Behavioral and Health Outcomes for HIV+ Young Transgender Women (YTW) Linked To and Engaged in Medical Care. LGBT Health 3:162-7|
|Barrett, Jeffrey S; Spitsin, Sergei; Moorthy, Ganesh et al. (2016) Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV. J Transl Med 14:148|
|Douglas, Steven D (2016) Substance P and sickle cell disease-a marker for pain and novel therapeutic approaches. Br J Haematol 175:187-188|
|Lyons, Anita; Bilker, Warren B; Hines, Janet et al. (2016) Effect of format on comprehension of adherence data in chronic disease: A cross-sectional study in HIV. Patient Educ Couns 99:154-9|
|McGuire, Jennifer L; Gill, Alexander J; Douglas, Steven D et al. (2016) The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth. J Neurovirol 22:823-830|
|Greeson, Jeffrey M; Gettes, David R; Spitsin, Sergei et al. (2016) The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune Cells. Biol Psychiatry 80:33-9|
|McGuire, Jennifer L; Gill, Alexander J; Douglas, Steven D et al. (2015) Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neurovirol 21:439-48|
|Springer, Sandra A; Larney, Sarah; Alam-Mehrjerdi, Zahra et al. (2015) Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions. J Acquir Immune Defic Syndr 69 Suppl 2:S155-61|
|Yehia, Baligh R; Stephens-Shield, Alisa J; Momplaisir, Florence et al. (2015) Health Outcomes of HIV-Infected People with Mental Illness. AIDS Behav 19:1491-500|
|McGuire, Jennifer L; Kempen, John H; Localio, Russell et al. (2015) Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth. Clin Vaccine Immunol 22:27-36|
Showing the most recent 10 out of 23 publications